{"resourceType":"Observation","id":"b86a349e-1b23-5f37-ac75-3ec481e5036a","meta":{"versionId":"1","lastUpdated":"2022-05-24T15:32:37.215-04:00","source":"#LmwRQ7lsaxuwhGEp","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"9866330-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/87dd177c-b3f5-584e-bf76-86e2ee047c1f"},"effectiveDateTime":"2128-05-28T15:00:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/2543d6f5-46b9-5de9-9c8a-22c45a432ce9"}}